FindMyKOL
Clinical trialNCT04681638TerminatedPhase 4Interventional

Plasma Resuscitation Without Lung Injury

SponsorCoalition for National Trauma ResearchEnrollment13Burns
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The treatment of patients with major burns requires resuscitation with massive amounts of fluid, typically a type of salt water that is given by vein. This frequently results in injury to vital organs, especially the lungs and kidneys, and even in death. In this study, the investigators propose to use plasma, a specially prepared blood product made from the liquid part of blood, that has undergone special treatment to reduce the risk of disease transmission. The aims include 1) reduce the amount of fluid given during the first 24 hours after a burn 2) reduce the incidence of lung injury and other complications related to the administration of funds and 3) determine if the blood product has any effect on inflammation. An overall decrease the amount of fluids that burn patients receive should decrease the potential for lung injury, decrease days in the hospital, and improve survival.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham Burn Center

    Birmingham, Alabama, United States

  • University of Maryland School of Medicine

    Baltimore, Maryland, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • U.S. Army Burn Center

    Fort Sam Houston, Texas, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • University of Washington School of Medicine

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Crystalloid SolutionsPathogen-Reduced Plasma
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Aug 2022
Primary completion
29 Jun 2024
Completion
29 Sept 2024
Last update posted
29 Jan 2025
Registered enrollment
13
Registry id
NCT04681638

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.